Skip to main content
. 2018 Nov 20;18:1141. doi: 10.1186/s12885-018-5033-y

Fig. 6.

Fig. 6

Downregulation of OGT increased the sensitivity of bladder cancer cells to cisplatin. T24 (a) and UMUC-3 (b) cell were transfected with LV-sh-OGT or LV-sh-NC, and then treated with various concentrations (0, 1, 2.5, 5, and 10 μM) of cisplatin. The cell viability was detected at various time points